But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

GSK (NYSE:GSK) has received Chinese regulatory approval for its drug Nucala, also known as mepolizumab, for the treatment of ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

In 2020, an expert consensus developed an initial framework for remission in asthma that includes a sustained absence of ...

"This evidence exemplifies how GPs are adapting their prescribing practices in line with evidence-based recommendations, ensuring patients benefit from advances in treatment." The two-in-one inhaler ...

Tools You Can Use to Control Winter Asthma, Allergy Symptoms WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- Winter is here, and that can make it difficult for those with asthma to control their ...

You may have recently heard about SMART (Single Maintenance and Reliever Therapy). It’s a somewhat new approach to asthma management that combines the use of a single inhaler for both ...

Macrolides reduce exacerbations when added to inhaled therapy in severe asthma. However, there is little published evidence for effectiveness in patients treated with biologics. We conducted a ...

VRG201 is an oral, first-in-class therapy that aims to correct the underlying metabolic dysfunction leading to obesity and help patients sustain weight loss while freeing them from significant ...